Mixed lichenoid and psoriasiform drug eruption induced by rifampicin
Sign Up to like & getrecommendations! Published in 2019 at "Australasian Journal of Dermatology"
DOI: 10.1111/ajd.13222
Abstract: Rifampicin is an essential first line anti‐tuberculosis drug. However, several cases of adverse reactions associated with this drug have been reported, the most common of which are cutaneous drug reactions. We report a case of… read more here.
Keywords: mixed lichenoid; lichenoid psoriasiform; drug; eruption induced ... See more keywords